CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $38,305,732 | +972.4% | 2,472,933 | +1003.6% | 0.04% | +875.0% |
| Q1 2024 | $3,571,883 | +112.8% | 224,083 | +124.4% | 0.00% | +100.0% |
| Q4 2023 | $1,678,394 | +52.1% | 99,845 | +5.8% | 0.00% | +100.0% |
| Q3 2023 | $1,103,173 | -50.1% | 94,369 | -42.6% | 0.00% | -66.7% |
| Q2 2023 | $2,208,769 | -29.1% | 164,343 | -1.8% | 0.00% | -25.0% |
| Q4 2022 | $3,114,291 | +211.4% | 167,435 | +17.4% | 0.00% | +300.0% |
| Q2 2022 | $1,000,000 | -18.0% | 142,629 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $1,219,000 | +15.8% | 147,031 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $1,053,000 | +45.8% | 155,566 | +14.3% | 0.00% | 0.0% |
| Q3 2021 | $722,000 | -48.5% | 136,158 | -44.2% | 0.00% | -50.0% |
| Q2 2021 | $1,403,000 | +20.0% | 244,062 | -3.7% | 0.00% | +100.0% |
| Q1 2021 | $1,169,000 | +50.1% | 253,563 | +8.7% | 0.00% | 0.0% |
| Q4 2020 | $779,000 | +7.7% | 233,210 | -4.2% | 0.00% | 0.0% |
| Q3 2020 | $723,000 | – | 243,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |